Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease
- PMID: 20728571
- PMCID: PMC3089422
- DOI: 10.1016/j.cgh.2010.08.005
Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease
Abstract
Background & aims: In overnourished individuals, impaired peripheral fat storage (ie, reduced fat mass in extremities) can increase delivery of surplus calories to the organs other than peripheral adipose tissues, including the liver (ie, lipid overload), and facilitate disease progression in patients with nonalcoholic fatty liver disease (NAFLD). We investigated whether peripheral and/or abdominal adipose depot size correlates with stage of hepatic fibrosis in patients with NAFLD in sex- and/or menopausal stage-specific manners.
Methods: We performed a cross-sectional analysis of 537 adult patients with NAFLD. Peripheral adipose depot size was defined as the sum of z-scores of 2 anthropometric parameters (middle upper arm circumference and hip circumference, relative to total body size) and expressed as extremity size. Abdominal adipose depot size was defined as waist circumference. Peripheral and abdominal adipose depot sizes were associated with fibrosis stage(s) (F0-F4) using multivariable analyses separately for men and pre- and post-menopausal women.
Results: After adjusting for caloric intake and energy expenditure during physical activity (MET; hours/week), peripheral and/or abdominal adipose depot sizes were differentially associated with fibrosis stages in men and pre- and post-menopausal women. Men with smaller extremity size, premenopausal women with larger extremity size, and postmenopausal women with larger abdominal size were more likely to have higher stages of fibrosis.
Conclusions: In patients with NAFLD, regional anthropometric measures are associated with fibrosis severity in a sex- and menopausal stage-specific manner. Unlike premenopausal women, men with NAFLD who have small peripheral adipose depots are at an increased risk of having advanced fibrosis.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
The authors disclose no conflicts.
Figures

Similar articles
-
Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2013 Feb;37(4):455-63. doi: 10.1111/apt.12198. Epub 2013 Jan 7. Aliment Pharmacol Ther. 2013. PMID: 23293873
-
Sex- and reproductive status-specific relationships between body composition and non-alcoholic fatty liver disease.BMC Gastroenterol. 2023 Oct 24;23(1):364. doi: 10.1186/s12876-023-02997-9. BMC Gastroenterol. 2023. PMID: 37875811 Free PMC article.
-
Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.Eur J Gastroenterol Hepatol. 2019 Nov;31(11):1460-1466. doi: 10.1097/MEG.0000000000001431. Eur J Gastroenterol Hepatol. 2019. PMID: 31045630
-
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.Adv Exp Med Biol. 2024;1460:539-574. doi: 10.1007/978-3-031-63657-8_18. Adv Exp Med Biol. 2024. PMID: 39287864 Review.
-
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Adv Ther. 2017 Jun;34(6):1291-1326. doi: 10.1007/s12325-017-0556-1. Epub 2017 May 19. Adv Ther. 2017. PMID: 28526997 Free PMC article. Review.
Cited by
-
Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.J Endocrinol Invest. 2022 Sep;45(9):1609-1623. doi: 10.1007/s40618-022-01766-x. Epub 2022 Mar 18. J Endocrinol Invest. 2022. PMID: 35303270 Review.
-
NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.Endocrinology. 2020 Oct 1;161(10):bqaa134. doi: 10.1210/endocr/bqaa134. Endocrinology. 2020. PMID: 32776116 Free PMC article. Review.
-
NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities.Curr Hepatol Rep. 2019 Dec;18(4):425-432. doi: 10.1007/s11901-019-00495-9. Epub 2019 Nov 18. Curr Hepatol Rep. 2019. PMID: 32523869 Free PMC article.
-
NASH in Special Populations.Gastroenterol Hepatol (N Y). 2014 Apr;10(4):262-4. Gastroenterol Hepatol (N Y). 2014. PMID: 24976812 Free PMC article. No abstract available.
-
Association between puberty and features of nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol. 2012 Jul;10(7):786-94. doi: 10.1016/j.cgh.2012.01.020. Epub 2012 Feb 14. Clin Gastroenterol Hepatol. 2012. PMID: 22343513 Free PMC article.
References
-
- Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79. - PubMed
-
- Huang KC. Obesity and its related diseases in Taiwan. Obes Rev. 2008;9 Suppl 1:32–34. - PubMed
-
- Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–2102. - PubMed
-
- Schröder H, Elosua R, Vila J, et al. Secular trends of obesity and cardiovascular risk factors in a Mediterranean population. Obesity (Silver Spring) 2007;15:557–562. - PubMed
-
- Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40 Suppl 1:S5–S10. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous